Prolonged extracorporeal life support for bridging to transplant: technical and mechanical considerations

E A Frazier1, S C Faulkner, P M Seib

  • 1Department of Pediatric Cardiology, Arkansas Children's Hospital, Little Rock 72202-3591, USA.

Perfusion
|March 1, 1997
PubMed

Insights

Extracorporeal life support (ECLS) can be a successful bridge to cardiac transplantation for pediatric patients. This method demonstrated an 88% recovery or transplant rate, with 76% of patients discharged home.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Critical Care Medicine

Background:

  • Extracorporeal Life Support Organization (ELSO) registry data shows a 41% survival rate for extracorporeal life support (ECLS) as a bridge to cardiac transplantation.
  • Pediatric patients with severe heart conditions often require advanced support to improve outcomes.

Purpose of the Study:

  • To evaluate the efficacy and safety of ECLS as a bridge to cardiac transplantation in pediatric patients.
  • To assess the impact of left-heart decompression and infection management on ECLS outcomes.

Main Methods:

  • Retrospective analysis of 17 pediatric patients treated with ECLS at Arkansas Children's Hospital.
  • Patients diagnosed with dilated cardiomyopathy, postcardiotomy, or acute viral myocarditis were included.
  • Left-heart decompression strategies and infection management protocols were documented.

Main Results:

  • 17 pediatric patients (2 days to 24 years) received ECLS.
  • Mechanical complications were minimal (2/17), and only one patient died from infection.
  • Fifteen of 17 patients (88%) were successfully bridged to recovery or cardiac transplantation, with 13 (76%) discharged home.

Conclusions:

  • ECLS is a viable and effective bridge to cardiac transplantation in pediatric patients.
  • Left-heart decompression and prompt infection treatment are crucial for improving ECLS outcomes.
  • ECLS can serve as a bridge to transplantation or support until native cardiac function returns.